| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8e0c2b83e1e3ee49f788f0847adad96 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-18 |
| filingDate |
1997-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1999-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4dd71b273fdb1cfd2165cb06ab68cbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb23adc8dd142c4488c93956a68f58b8 |
| publicationDate |
1999-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5998131-A |
| titleOfInvention |
Screening methods for the identification of compounds capable of abrogating BaK-BHRF-1 protein interactions |
| abstract |
The present invention provides methods for screening potential anti-viral therapeutic agents by monitoring their ability to disrupt the interaction between the BAK protein and a viral protein. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009155834-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8546074-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8546090-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2024511-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8652797-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7097982-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010240029-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2024511-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8642284-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011218229-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004054129-A1 |
| priorityDate |
1994-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |